Background
Toxoplasmic encephalitis (TE) is a life-threatening complication of people with HIV (PWH) with severe immunodeficiency, especially those with a CD4+ T cell count under 100 cells/mm3. Following a clinical response to anti-Toxoplasma therapy, and immune reconstitution after initiation of combination anti-retroviral therapy (ART), anti-Toxoplasma therapy can be discontinued with a low risk of relapse.
Methods
To better understand the evolution of MRI-defined TE lesions in PWH receiving ART, we undertook a retrospective study of PWH initially seen at the NIH between 2001 and 2012, who had at least 2 serial MRI scans. Lesion size and change over time were calculated and correlated with clinical parameters.
Results
Among 24 PWH with TE and serial MRI scans, only 4 had complete clearance of lesions at the last MRI (follow-up, 0.09 to 5.8 years). Of 10 PWH off all anti-Toxoplasma therapy (median, 3.2 years after TE diagnosis), 6 had persistent MRI enhancement. In contrast, all 5 PWH seen in a pre-ART era study who were followed for >6 months had complete clearance of lesions. TE lesion area at diagnosis was associated with the absolute change in area (p < 0.0001).
Conclusions
Thus, contrast enhancement can persist even when TE has been successfully treated and anti-Toxoplasma therapy has been stopped, highlighting the need to consider diagnostic alternatives in successfully treated patients with immune reconstitution presenting with new neurologic symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.